PEMBROLIZUMAB

pembrolizumab 100 mg/4 mL injection, 4 mL vial

PEMBROLIZUMAB (11494Y)

pembrolizumab 100 mg/4 mL injection, 4 mL vial
11494Y
Body System:
Manner of administration:Injection
Public
Chemotherapy Items for Public Hospital use
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 18373)

Indication: Stage IV (metastatic) non-small cell lung cancer (NSCLC)
Treatment phase: Initial treatment - 3 weekly treatment regimen

Restriction (Streamlined authority code: 13432)

Indication: Stage IV (metastatic) non-small cell lung cancer (NSCLC)
Treatment phase: Continuing treatment - 3 weekly treatment regimen
Quantities & Cost
Max amount # of repeats DPMA Max safety net General Patient Charge
Max amount: 200 mg # of repeats: 6 DPMA: $7,356.35 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Keytruda
(pembrolizumab 100 mg/4 mL injection, 4 mL vial)